4//SEC Filing
Jimenez Freddy A. 4
Accession 0001415889-24-015950
CIK 0000744218other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:05 PM ET
Size
7.1 KB
Accession
0001415889-24-015950
Insider Transaction Report
Form 4
Jimenez Freddy A.
SVP & GENERAL COUNSEL
Transactions
- Exercise/Conversion
Common Stock
2024-06-05$10.38/sh+9,540$99,025→ 35,464 total - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2024-06-05−9,540→ 18,454 totalExercise: $10.38Exp: 2030-06-18→ Common Stock (9,540 underlying)
Footnotes (1)
- [F1]25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001838114
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:05 PM ET
- Size
- 7.1 KB